http://www.ptca.org/ Breaking news about stents, angioplasty, the medical device industry, balloons, diagnostic imaging, interventional cardiology, stent thrombosis, restenosis from Angioplasty.Org en-us copyright 2006-10 Venture Digital LLC Mon, 25 Jan 2010 21:30:00 EST http://www.ptca.org/images/nav/angio_logo1.gif http://www.ptca.org/ http://www.ptca.org/news/2010/0205_VOLCANO.html http://www.ptca.org/news/2010/0205_VOLCANO.html Volcano Corporation (Nasdaq: VOLC) today announced that the jury in the litigation filed by Lightlab Imaging, Inc. on January 7, 2009 in the Superior Court of Massachusetts, Suffolk County reached a verdict against Volcano and its wholly owned subsidiary, Axsun Technologies. Fri, 05 Feb 2010 16:35:00 EST http://www.ptca.org/news/2010/0126_CARDIUM.html http://www.ptca.org/news/2010/0126_CARDIUM.html Cardium Therapeutics (NYSE Amex: CXM) has provided an update on plans for the continuing commercial development of Generx(TM) a DNA-based angiogenic therapy product candidate for patients with coronary artery disease. Tue, 26 Jan 2010 20:15:00 EST http://www.ptca.org/news/2010/0126_MEDTRONIC.html http://www.ptca.org/news/2010/0126_MEDTRONIC.html With the FDA's approval of its Melody Transcatheter Pulmonary Valve, the first percutaneous valve to be approved in the U.S., and its acquisition of European-based Invatec, Medtronic is positioning itself to expand its interventional cardiology portfolio well beyond the coronary arteries. Tue, 26 Jan 2010 19:25:00 EST http://www.ptca.org/news/2010/0125_EARTHQUAKE.html http://www.ptca.org/news/2010/0125_EARTHQUAKE.html In the two weeks since a devastating earthquake struck Haiti, the major U.S.-based stent manufacturers have responded by pledging over three million dollars of aid for both immediate and long-term relief efforts. Mon, 25 Jan 2010 21:30:00 EST http://www.ptca.org/news/2010/0115_MEDTRONIC.html http://www.ptca.org/news/2010/0115_MEDTRONIC.html Medtronic, Inc. (NYSE: MDT) announced today that it has pledged $150,000 through the Medtronic Foundation to support earthquake relief efforts in Haiti. The Foundation will match employee donations up to $50,000, with matching funds directed to Partners in Health. An additional $100,000 grant will be directed to the rebuilding of community health clinics in Haiti. Employees worldwide also are offered five days of paid leave to assist in recovery efforts. Sat, 16 Jan 2010 18:45:00 EST http://www.ptca.org/news/2010/0111_VOLCANO.html http://www.ptca.org/news/2010/0111_VOLCANO.html Volcano Corporation (Nasdaq: VOLC) said today that it expects total revenues for fiscal 2009 will be approximately $228.0 million, with revenues in the fourth quarter of fiscal 2009 expected to be approximately $71.0 million, reflecting year-over-year revenue growth of approximately 33 percent. Mon, 11 Jan 2010 12:30:00 EST http://www.ptca.org/news/2010/0105_02_VOLCANO.html http://www.ptca.org/news/2010/0105_02_VOLCANO.html Volcano Corporation (Nasdaq: VOLC) said today that it will be participating in the 28th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12. The presentation by Scott Huennekens, president and chief executive officer, will begin at 2 p.m., Pacific Standard Time, (5 p.m., Eastern Standard Time). Wed, 06 Jan 2010 13:00:00 EST http://www.ptca.org/news/2010/0105_01_VOLCANO.html http://www.ptca.org/news/2010/0105_01_VOLCANO.html Volcano Corporation (Nasdaq: VOLC) announced today receipt of CE mark for their OCT (Optical Coherence Tomography) imaging system and catheter. Volcano's OCT product line is expected to complement its existing line of IVUS imaging catheters and pressure guide wires used for coronary imaging and lesion assessment. Tue, 05 Jan 2010 14:40:00 EST http://www.ptca.org/news/2009/1215_VOLCANO.html http://www.ptca.org/news/2009/1215_VOLCANO.html Volcano Corporation (Nasdaq: VOLC), a leading developer of precision intravascular therapy guidance tools - including Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Forward Looking IVUS and Optical Coherence Tomography (OCT) - designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today the placement of over 2,500 s5 family consoles worldwide. The s5 family of consoles was first launched in April 2006, with more than 1,000 systems placed in the last 12 months alone. Tue, 15 Dec 2009 16:20:00 EST http://www.ptca.org/news/2009/1208_MEDTRONIC.html http://www.ptca.org/news/2009/1208_MEDTRONIC.html Medtronic, Inc. (NYSE: MDT), today announced the hire of Prof. Martin Rothman as vice president of medical affairs for the company's coronary and peripheral vascular business. Prof. Rothman will join Medtronic after 37 years of clinical practice in the U.K. as an interventional cardiologist. He is world renowned for his contributions to clinical research, training and education, and medical technology innovation in cardiovascular medicine. Tue, 08 Dec 2009 12:00:00 EST http://www.ptca.org/news/2009/1205_RADIAL_TCT.html http://www.ptca.org/news/2009/1205_RADIAL_TCT.html This fall's Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Francisco offered a unique and important session, "The Transradial Angiography and Intervention Seminar", comprising an entire afternoon with over twenty separate presentations by global leaders in the field of stents and angioplasty, as performed from the wrist. The complete session is now available online at the TCT's website, TCTMD.com Sat, 05 Dec 2009 22:00:00 EST http://www.ptca.org/news/2009/1204_VOLCANO.html http://www.ptca.org/news/2009/1204_VOLCANO.html Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC), today announced the initial development and successful testing of its novel integrated High Definition Swept Source -- or HDSS(tm) -- which is based on a non-laser source of photons. The HDSS is expected to enable high resolution at unprecedented speeds in medical imaging systems. Axsun believes this proprietary optical engine design raises the bar on imaging speed and overcomes fundamental limitations of laser-based designs for swept source OCT light sources. Fri, 04 Dec 2009 15:10:00 EST http://www.ptca.org/news/2009/1202_MEDTRONIC.html http://www.ptca.org/news/2009/1202_MEDTRONIC.html Medtronic, Inc. (NYSE:MDT), today announced the appointment of Michael J. Coyle as executive vice president and group president of its Cardiology businesses. Coyle will lead all aspects of the group, which includes the company's Cardiac Rhythm Disease Management (CRDM), CardioVascular and Physio-Control businesses. He will be a member of the Executive Committee and report to Chairman and CEO Bill Hawkins. Wed, 02 Dec 2009 12:00:00 EST http://www.ptca.org/news/2009/1124_MEDTRONIC.html http://www.ptca.org/news/2009/1124_MEDTRONIC.html "Our solid financial performance this quarter was driven by consistent execution across our diversified portfolio of businesses," said Bill Hawkins, Medtronic chairman and chief executive officer. "We are well-positioned to deliver on our commitments for the balance of our fiscal year and to launch innovative new products to drive further growth in the coming years." Mon, 30 Nov 2009 15:40:00 EST http://www.ptca.org/news/2009/1125_MEDTRONIC.html http://www.ptca.org/news/2009/1125_MEDTRONIC.html Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 21st Annual Piper Jaffray Healthcare Conference on Tuesday, Dec. 1, 2009, in New York. Mon, 30 Nov 2009 15:10:00 EST http://www.ptca.org/news/2009/1124_VOLCANO.html http://www.ptca.org/news/2009/1124_VOLCANO.html Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the 21st Annual Piper Jaffray Health Care Conference on Tuesday, December 1. Mon, 30 Nov 2009 14:25:00 EST http://www.ptca.org/news/2009/1125_FFR.html http://www.ptca.org/news/2009/1125_FFR.html The use of Fractional Flow Reserve (FFR) to determine whether or not to treat a coronary blockage with angioplasty or stents has received a boost from the newly released "Focused Updates to the ACC/AHA/SCAI Guidelines on Percutanous Coronary Intervention." Wed, 25 Nov 2009 14:10:00 EST http://www.ptca.org/news/2009/1109_VOLCANO.html http://www.ptca.org/news/2009/1109_VOLCANO.html Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Third Annual Canaccord Cardiovascular Conference on Tuesday, November 10. Mon, 09 Nov 2009 20:55:00 EST http://www.ptca.org/news/2009/1107_BAIM.html http://www.ptca.org/news/2009/1107_BAIM.html Interventional cardiologist, Donald S. Baim, died yesterday following surgery, performed to treat a rare form of cancer that attacks the adrenal glands. He was 60. Baim was one of the pioneers of interventional cardiology, having worked with John Simpson at Stanford in the early days of balloon angioplasty. Sat, 07 Nov 2009 18:25:00 EST http://www.ptca.org/news/2009/1105_VOLCANO.html http://www.ptca.org/news/2009/1105_VOLCANO.html Volcano Corporation (Nasdaq: VOLC) today reported revenues of $53.9 million for the third quarter of fiscal 2009. The results for the quarter ended September 30, 2009, represent an increase of 22 percent over revenues of $44.1 million in the third quarter of 2008. Thu, 05 Nov 2009 17:00:00 EST